Elranatamab Post Trial Access Study for Participants With Multiple Myeloma (MM)

Part of paid clinical trials in Irvine, California.

Sponsor
Pfizer
Study ID
NCT06057402
Phase
PHASE4
Status
Recruiting
Apply to this trial

Conditions

Eligibility Criteria

Sex
ALL
Age
18 Years - N/A
Healthy Volunteers
Not accepted

Interventions

  • Elranatamab — DRUG
    Elranatamab is a heterodimeric humanized full-length bispecific IgG2 kappa antibody that targets BCMA on MM cells and CD3 on T cells

Study Details

This is a post-trial access (PTA) open-label, single-arm study in Multiple Myeloma participants who continue to derive clinical benefit from elranatamab monotherapy in the Pfizer-sponsored elranatamab Parent Studies.

Key Dates

First listed
Sep 28, 2023
Start date
Oct 3, 2023
Status verified
Jun 2026
Primary completion
Feb 22, 2032
Completion
Feb 22, 2032

Study Design

Enrollment
80 participants (estimated)
Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT

Arms

  • Experimental: Elranatamab
    Elranatamab is a heterodimeric humanized full length bispecific IgG2 kappa antibody that targets BCMA on MM cells and CD3 on T cells

Primary Outcome Measure

Incidence of nonserious adverse events (AEs) leading to permanent discontinuation [ Time Frame: A minimum of 90 days after the last dose of study drug ]

Central Contacts

Locations (17)

FacilityCityStateZIPSite coordinators
UCI Health - Irvine Infusion Pharmacy ACCIrvineCalifornia92612-
UC Irvine HealthOrangeCalifornia92612-
UCI HealthOrangeCalifornia92868-
UCHealth HarmonyFort CollinsColorado80528-
UCHealth Poudre Valley HospitalFort CollinsColorado80524-
UCHealth Greeley HospitalGreeleyColorado80634-
Longs Peak HospitalLongmontColorado80504-
UCHealth Longs Peak Medical CenterLongmontColorado80504-
UCHealth - Medical Center of the RockiesLovelandColorado80538-
Sylvester Comprehensive Cancer Center - The Lennar Foundation Medical CenterCoral GablesFlorida33146-
University of Miami Hospital and Clinics Deerfield BeachDeerfield BeachFlorida33442-
Sylvester Comprehensive Cancer CenterMiamiFlorida33136-
University of Miami Hospital and ClinicsMiamiFlorida33136-
University of Miami Hospital and Clinics - Griffin Cancer Research BuildingMiamiFlorida33136-
University of MichiganAnn ArborMichigan48109-
Henry Ford Cancer - Detroit (Brigitte Harris Cancer Pavilion)DetroitMichigan48202-
St. David's South Austin Medical CenterAustinTexas78704-

Find similar trials in Irvine, CA

By condition
Multiple myeloma
By specialty
OncologyBlood cancer
By research site
UCI Health - Irvine Infusion Pharmacy ACC· Irvine, CAUC Irvine Health· Orange, CAUCI Health· Orange, CAUCHealth Harmony· Fort Collins, COUCHealth Poudre Valley Hospital· Fort Collins, COUCHealth Greeley Hospital· Greeley, CO

Related Studies